Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Rujescu

Showing results (281-290 of 480) with videos related to

Pageof 48
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|September 12, 2012
No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depressionRichard Musil, Peter Zill, Florian Seemüller, et al.
Pteridines|September 26, 2017
Reciprocal moderation by <i>Toxoplasma gondii</i> seropositivity and blood phenylalanine - tyrosine ratio of their associations with trait aggressionAshwin Jacob Mathai, Christopher A Lowry, Thomas B Cook, et al.
Human Brain Mapping|December 19, 2015
Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PETHelen L Sigurdardottir, Georg S Kranz, Christina Rami-Mark, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 21, 2025
Correction: Mild motor signs and depression: more than just medication side effects?Antonina Luca, Maria Luca, Siegfried Kasper, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 4, 2017
Investigation of SHANK3 in schizophreniaAna de Sena Cortabitarte, Franziska Degenhardt, Jana Strohmaier, et al.
Frontiers in Public Health|January 9, 2014
A Positive Association between T. gondii Seropositivity and ObesityGloria M Reeves, Sara Mazaheri, Soren Snitker, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 16, 2012
Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episodeRichard Musil, Peter Zill, Florian Seemüller, et al.
Journal of Psychiatric Research|June 30, 2026
Cumulative depressive burden, functional impairment, depressive symptomatology and treatment response in Major Depressive Disorder: results from the STAR∗D and GSRD studiesMaria Luca, Paolo Olgiati, Antonina Luca, et al.
Schizophrenia Bulletin|March 10, 2015
Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for interventionRichard J Drake, Merete Nordentoft, Gillian Haddock, et al.
Cell|March 6, 2012
Interplay between DISC1 and GABA signaling regulates neurogenesis in mice and risk for schizophreniaJu Young Kim, Cindy Y Liu, Fengyu Zhang, et al.
Pageof 48

Showing results (281-290 of 480) with videos related to

Sort By:
Pageof 48
European Archives of Psychiatry and Clinical Neuroscience|September 12, 2012
No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depressionRichard Musil, Peter Zill, Florian Seemüller, et al.
Pteridines|September 26, 2017
Reciprocal moderation by <i>Toxoplasma gondii</i> seropositivity and blood phenylalanine - tyrosine ratio of their associations with trait aggressionAshwin Jacob Mathai, Christopher A Lowry, Thomas B Cook, et al.
Human Brain Mapping|December 19, 2015
Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PETHelen L Sigurdardottir, Georg S Kranz, Christina Rami-Mark, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 21, 2025
Correction: Mild motor signs and depression: more than just medication side effects?Antonina Luca, Maria Luca, Siegfried Kasper, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 4, 2017
Investigation of SHANK3 in schizophreniaAna de Sena Cortabitarte, Franziska Degenhardt, Jana Strohmaier, et al.
Frontiers in Public Health|January 9, 2014
A Positive Association between T. gondii Seropositivity and ObesityGloria M Reeves, Sara Mazaheri, Soren Snitker, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 16, 2012
Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episodeRichard Musil, Peter Zill, Florian Seemüller, et al.
Journal of Psychiatric Research|June 30, 2026
Cumulative depressive burden, functional impairment, depressive symptomatology and treatment response in Major Depressive Disorder: results from the STAR∗D and GSRD studiesMaria Luca, Paolo Olgiati, Antonina Luca, et al.
Schizophrenia Bulletin|March 10, 2015
Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for interventionRichard J Drake, Merete Nordentoft, Gillian Haddock, et al.
Cell|March 6, 2012
Interplay between DISC1 and GABA signaling regulates neurogenesis in mice and risk for schizophreniaJu Young Kim, Cindy Y Liu, Fengyu Zhang, et al.
Pageof 48